Shares of Valneva (NASDAQ:VALN) traded higher on Wednesday after the French biotech announced that the U.K.’s Medicines and Healthcare Products Regulatory Agency granted marketing authorization for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback